STAPLETON RAYMOND D JR 4
4 · GENOCEA BIOSCIENCES, INC. · Filed Mar 17, 2022
Insider Transaction Report
Form 4
STAPLETON RAYMOND D JR
EVP PHARM SCI & MFG
Transactions
- Award
Common Stock
2022-03-15+43,750→ 46,250 total - Award
Stock Option (Right to Buy)
2022-03-15+131,250→ 131,250 totalExercise: $1.11Exp: 2032-03-15→ Common Stock (131,250 underlying)
Footnotes (2)
- [F1]Restricted stock units that represent the contingent right to receive, at settlement, one share of common stock. The restricted stock units are scheduled to vest 25% on each of the first four anniversaries of the grant date.
- [F2]The options are scheduled to vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.